DESCRIPTION Meclizine hydrochloride , an oral antiemetic , is a white , slightly yellowish , crystalline powder which has a slight odor and is tasteless .
It has the following structural formula : [ MULTIMEDIA ] C25H27CIN2 • 2 HCI • H2O M . W . 481 . 89 The chemical name is 1 - ( p - chloro - alpha - phenylbenzyl ) - 4 - ( m - methyl - benzyl ) - piperazine dihydrochloride monohydrate .
Meclizine Hydrochloride Tablets are available in 12 . 5 mg , and * 25 mg strengths for oral administration .
* Contains FD & C Yellow # 5 ( see PRECAUTIONS ) .
Each tablet contains the following inactive ingredients : colloidal silicon dioxide , lactose , magnesium stearate , microcrystalline cellulose , sodium starch glycolate , starch , and stearic acid .
In addition , the 12 . 5 mg tablet contains FD & C Blue # 1 ; and the 25 mg tablet contains D & C Yellow # 10 and FD & C Yellow # 5 .
[ MULTIMEDIA ] CLINICAL PHARMACOLOGY Meclizine hydrochloride is an antihistamine which shows marked protective activity against nebulized histamine and lethal doses of intravenously injected histamine in guinea pigs .
It has a marked effect in blocking the vasodepressor response to histamine , but only a slight blocking action against acetylcholine .
Its activity is relatively weak in inhibiting the spasmogenic action of histamine on isolated guinea pig ileum .
INDICATIONS AND USAGE For the prevention and treatment of nausea , vomiting , or dizziness associated with motion sickness .
CONTRAINDICATIONS Meclizine hydrochloride is contraindicated in individuals who have shown a previous hypersensitivity to it .
WARNINGS Since drowsiness may , on occasion , occur with use of this drug , patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery .
Patients should avoid alcoholic beverages while taking the drug .
Due to its potential anticholinergic action , this drug should be used with caution in patients with asthma , glaucoma , or enlargement of the prostate gland .
Do not give to children under 12 years of age unless directed by a doctor .
PRECAUTIONS The Meclizine Hydrochloride Tablets , 25 mg contain FD & C Yellow # 5 ( tartrazine ) which may cause allergic - type reactions ( including bronchial asthma ) in certain susceptible individuals .
Although the overall incidence of FD & C Yellow # 5 ( tartrazine ) sensitivity in the general population is low , it is frequently seen in patients who also have aspirin hypersensitivity .
Usage in Children : Clinical studies establishing safety and effectiveness in children have not been done ; therefore , usage is not recommended under 12 years of age .
Usage in Pregnancy : Pregnancy Category B . Reproduction studies in rats have shown cleft palates at 25 - 50 times the human dose .
Epidemiological studies in pregnant women , however , do not indicate that meclizine hydrochloride increases the risk of abnormalities when administered during pregnancy .
Despite the animal findings , it would appear that the possibility of fetal harm is remote .
Nevertheless , meclizine hydrochloride , or any other medication should be used during pregnancy only if clearly necessary .
ADVERSE REACTIONS Drowsiness , dry mouth , and on rare occasions , blurred vision have been reported .
DOSAGE AND ADMINISTRATION Motion Sickness : The initial dose of 25 to 50 mg meclizine hydrochloride , should be taken one hour prior to travel for protection against motion sickness .
Thereafter , the dose may be repeated every 24 hours for the duration of the journey .
HOW SUPPLIED Meclizine Hydrochloride Tablets , USP 12 . 5 mg - blue , oval tablets debossed with “ 034 ” on one side and “ par ” on the other side .
Tablets may contain characteristic dye spots .
They are supplied in bottles of 100 ( NDC 49884 - 034 - 01 ) and 1000 ( NDC 49884 - 034 - 10 ) .
Meclizine Hydrochloride Tablets , USP 25 mg - yellow , oval tablets debossed with “ 035 ” on one side and “ par ” on the other side .
They are supplied in bottles of 100 ( NDC 49884 - 035 - 01 ) and 1000 ( NDC 49884 - 035 - 10 ) .
Dispense in tight , light - resistant containers as defined in the USP .
Store at controlled room temperature 15 ° - 30 ° C ( 59 ° - 86 ° F ) .
Manufactured by : PAR PHARMACEUTICAL COMPANIES , INC .
Spring Valley , NY 10977 Repacked by : H . J . Harkins Company , Inc .
Nipomo , CA 93444 Revised : 11 / 11 OS034 - 01 - 1 - 11 PRINCIPAL DISPLAY PANEL : 12 . 5 MG CONTAINER LABEL 100 TABLETS [ MULTIMEDIA ] [ MULTIMEDIA ]
